Healthcare provider profile · identity verified

Mark Morrissey

Family Practice · NATRONA HEIGHTS, PA · NPI 1205801867

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	670	193
Lisinopril	Lisinopril	441	129
Amlodipine Besylate	Amlodipine Besylate	437	128
Metformin Hcl	Metformin Hcl	307	91
Omeprazole	Omeprazole	298	84
Levothyroxine Sodium	Levothyroxine Sodium	296	85
Metoprolol Tartrate	Metoprolol Tartrate	277	77
Gabapentin	Gabapentin	260	67
Losartan Potassium	Losartan Potassium	252	74
Simvastatin	Simvastatin	252	72
Alprazolam	Alprazolam	236	50
Eliquis	Apixaban	204	45
Prednisone	Prednisone	204	114
Furosemide	Furosemide	202	70
Hydrochlorothiazide	Hydrochlorothiazide	197	62
Tamsulosin Hcl	Tamsulosin Hcl	174	50
Metoprolol Succinate	Metoprolol Succinate	171	54
Pantoprazole Sodium	Pantoprazole Sodium	171	45
Albuterol Sulfate Hfa	Albuterol Sulfate	147	42
Zolpidem Tartrate	Zolpidem Tartrate	146	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	143	43
Tramadol Hcl	Tramadol Hcl	139	46
Meloxicam	Meloxicam	129	42
Clopidogrel	Clopidogrel Bisulfate	116	31
Sertraline Hcl	Sertraline Hcl	115	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	19
Atenolol	Atenolol	97	29
Fluticasone Propionate	Fluticasone Propionate	93	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	23
Allopurinol	Allopurinol	89	27
Jardiance	Empagliflozin	82	21
Pravastatin Sodium	Pravastatin Sodium	81	23
Citalopram Hbr	Citalopram Hydrobromide	77	21
Azithromycin	Azithromycin	76	69
Famotidine	Famotidine	71	21
Lovastatin	Lovastatin	69	21
Spironolactone	Spironolactone	67	25
Lorazepam	Lorazepam	66	19
Pioglitazone Hcl	Pioglitazone Hcl	66	18
Rosuvastatin Calcium	Rosuvastatin Calcium	65	21
Alendronate Sodium	Alendronate Sodium	60	19
Clonazepam	Clonazepam	59	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	23
Carvedilol	Carvedilol	56	17
Ibuprofen	Ibuprofen	55	19
Potassium Chloride	Potassium Chloride	55	21
Escitalopram Oxalate	Escitalopram Oxalate	51	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	31
Enalapril Maleate	Enalapril Maleate	48	12
Ozempic	Semaglutide	47	13
Montelukast Sodium	Montelukast Sodium	45	11
Terbinafine Hcl	Terbinafine Hcl	45	11
Trazodone Hcl	Trazodone Hcl	45	13
Fluoxetine Hcl	Fluoxetine Hcl	44	16
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	15
Metformin Hcl Er	Metformin Hcl	40	13
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	11
Bisoprolol Fumarate	Bisoprolol Fumarate	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	12
Mounjaro	Tirzepatide	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	11
Donepezil Hcl	Donepezil Hcl	32	11
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	27
Hydroxyzine Hcl	Hydroxyzine Hcl	31	13
Meclizine Hcl	Meclizine Hcl	30	12
Amitriptyline Hcl	Amitriptyline Hcl	29	12
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Glipizide	Glipizide	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	16
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Baclofen	Baclofen	25	suppressed
Xarelto	Rivaroxaban	24	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	23	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Diazepam	Diazepam	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Metronidazole	Metronidazole	20	15
Terazosin Hcl	Terazosin Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Ibu	Ibuprofen	19	suppressed
Clonidine	Clonidine	18	suppressed
Indomethacin	Indomethacin	18	12
Januvia	Sitagliptin Phosphate	18	suppressed
Topiramate	Topiramate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Imipramine Hcl	Imipramine Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	11
Naproxen	Naproxen	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Fluconazole	Fluconazole	15	11
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Invokana	Canagliflozin	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Primidone	Primidone	12	suppressed
Risperidone	Risperidone	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error